Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04190862 · ClinicalTrials.gov registry record · Phase 1
E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas
A Phase 1 study of Anal Fistula, sponsored by Weill Medical College of Cornell University.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 39
- Enrollment target
- 1
- Study location
NCT04190862 is a Phase 1 study of Anal Fistula that is actively recruiting participants, run by Weill Medical College of Cornell University. The registered enrollment target is 39 participants, below the 294-participant average among 5 other Anal Fistula trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04190862, a Phase 1 study of Anal Fistula, is actively recruiting participants, sponsored by Weill Medical College of Cornell University.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 39 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine if endothelial cells derived from human umbilical vein are safe for use in conjunction with fistulotomy for the treatment of simple anal fistulas. Endothelial cells are a special kind of cell in the body that line the inside surface of blood vessels. The goal of the study is to evaluate the preliminary safety of human umbilical vein cells in anal fistula healing.
Conditions Studied
Interventions
- DRUG E-CEL UVEC
Study Locations (1)
New York
- Weill Cornell Medical College - NewYork-Presbyterian Hospital - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2020-01-22 |
| Est. Completion | 2032-06-30 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04190862
The ClinicalTrials.gov registry entry for NCT04190862 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 294-participant average among 5 other Anal Fistula trials with a reported enrollment target (87% lower). The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Anal Fistula appearing as the primary indexed condition, and to 1 intervention - of which E-CEL UVEC is the first listed.
NCT04190862 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT04190862 about?
NCT04190862 is a clinical study titled "E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas". The purpose of this study is to determine if endothelial cells derived from human umbilical vein are safe for use in conjunction with fistulotomy for the treatment of simple anal fistulas. Endothelial cells are a special kind of cell in the body that line the inside surface of blood vessels. The goa...
What is the current status of trial NCT04190862?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 39 participants. The study started on 2020-01-22. Estimated completion is 2032-06-30.
What conditions does trial NCT04190862 study?
This clinical trial studies the following conditions: Anal Fistula.
What interventions are being tested in trial NCT04190862?
The interventions under investigation include: E-CEL UVEC (DRUG).
Who is sponsoring clinical trial NCT04190862?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04190862 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anal Fistula
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
BIOlogic Augmented Repair of Complex Anal Fistula Using Acellular Matrix and/or Autologous Platelet-rich Plasma
RECRUITING · NA
-
A Double Blind, Randomized Controlled Study, Evaluating the Safety and Efficacy of RD2 Ver.02 For the Management of Anal Fistulas
RECRUITING · NA
-
Myriad™ Augmented Soft Tissue Reconstruction Registry
RECRUITING
-
Evaluating an rhPDGF-BB-enhanced Collagen Plug for Perianal Fistula Healing
ACTIVE NOT RECRUITING · Phase 2
-
Treatment of Perirectal Fistula With Cutting Seton vs. Collagen Plug
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.